Search

everythinglearnresearchcommunity

for

Search:↓

The study used monkeys to test a hair loss treatment called minoxidil, which showed positive results.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

Children's hairlines change shape as they grow, with women often developing a widow's peak and men's hairlines becoming more convex and possibly balding at the temples, influenced by genetics and hormones.

Less AgNOR protein production is linked to hair loss.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Finasteride and low-dose dutasteride combo improves hair growth and reduces hair loss with no major side effects.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Minoxidil use may cause skin pigmentation loss.

Advancements in hair transplantation have resulted in more natural-looking hair and increased patient satisfaction.

The transtemporal midface lift improves the lower eyelid and cheek area with high patient satisfaction and low complication rates.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

A woman developed a scalp condition from using minoxidil, which improved with a different treatment but left scarring.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Carbamazepine can cause hair loss, which may reverse when the medication is stopped.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Using a hair removal laser can make hairs finer for better hairline correction in hair transplants, with most patients happy and few side effects.

Hair restoration surgery redistributes existing hair to achieve a natural look, with visible regrowth in 3-4 months and rare complications, mostly aesthetic.

People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Valproic acid helped hair growth in alopecia patient; more research needed.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Temporal hair loss relates to overall scalp hair loss in women.

Lower hairlines using the rule of thirds can be used in hair transplants due to improved techniques.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Using tissue expanders for scalp reconstruction in patients with extensive Aplasia Cutis Congenita is effective and has minimal complications.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.